NCT05345613View on ClinicalTrials.gov

Tranexamic Acid During Colonic Endoscopic Resection Procedures

PHASE4RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

September 1, 2025

Study Completion Date

October 1, 2025

Conditions
Colon Neoplasm
Interventions
DRUG

Tranexamic acid

Submucosal injection of standard solution including TXA during EMR procedure

DRUG

Standard

Injection of standard solution

Trial Locations (1)

70300

RECRUITING

Shamir Medical Center, Be’er Ya‘aqov

All Listed Sponsors
lead

Assaf-Harofeh Medical Center

OTHER_GOV

NCT05345613 - Tranexamic Acid During Colonic Endoscopic Resection Procedures | Biotech Hunter | Biotech Hunter